Harbor Investment Advisory’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.1M | Buy |
10,198
+813
| +9% | +$87.3K | 0.1% | 159 |
|
2025
Q1 | $947K | Buy |
9,385
+3,428
| +58% | +$346K | 0.09% | 163 |
|
2024
Q4 | $532K | Sell |
5,957
-17
| -0.3% | -$1.52K | 0.05% | 227 |
|
2024
Q3 | $501K | Sell |
5,974
-388
| -6% | -$32.5K | 0.05% | 234 |
|
2024
Q2 | $490K | Buy |
6,362
+8
| +0.1% | +$616 | 0.05% | 229 |
|
2024
Q1 | $435K | Hold |
6,354
| – | – | 0.05% | 241 |
|
2023
Q4 | $367K | Buy |
6,354
+393
| +7% | +$22.7K | 0.04% | 247 |
|
2023
Q3 | $315K | Hold |
5,961
| – | – | 0.04% | 254 |
|
2023
Q2 | $322K | Buy |
5,961
+30
| +0.5% | +$1.62K | 0.04% | 277 |
|
2023
Q1 | $297K | Hold |
5,931
| – | – | 0.04% | 287 |
|
2022
Q4 | $274K | Sell |
5,931
-1,046
| -15% | -$48.4K | 0.04% | 295 |
|
2022
Q3 | $270K | Buy |
6,977
+363
| +5% | +$14K | 0.04% | 283 |
|
2022
Q2 | $247K | Hold |
6,614
| – | – | 0.04% | 299 |
|
2022
Q1 | $293K | Buy |
6,614
+117
| +2% | +$5.18K | 0.04% | 295 |
|
2021
Q4 | $276K | Buy |
6,497
+190
| +3% | +$8.07K | 0.03% | 309 |
|
2021
Q3 | $274K | Hold |
6,307
| – | – | 0.04% | 300 |
|
2021
Q2 | $270K | Hold |
6,307
| – | – | 0.04% | 309 |
|
2021
Q1 | $244K | Hold |
6,307
| – | – | 0.04% | 302 |
|
2020
Q4 | $227K | Sell |
6,307
-2,351
| -27% | -$84.6K | 0.04% | 291 |
|
2020
Q3 | $331K | Buy |
8,658
+280
| +3% | +$10.7K | 0.06% | 206 |
|
2020
Q2 | $294K | Buy |
8,378
+4,307
| +106% | +$151K | 0.06% | 208 |
|
2020
Q1 | $133K | Buy |
4,071
+4,054
| +23,847% | +$132K | 0.04% | 274 |
|
2019
Q4 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 797 |
|